Antiangiogenic and Antitumoral Effects Mediated by a Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1)-Targeted DNAzyme

Table 4 Hematological parameters.

	Erythrocytes (10¹² g/L)	Leucocytes (10⁹ g/L)	Hemoglobin (g/L)	Platelets (10⁹ g/L)	Neutrophil (10⁹ g/L)	Lymphocytes (10⁹ g/L)
Saline	8.89 ± 0.56	2.85 ± 0.74	154.25 ± 4.65	1024.5 ± 84.5	0.25 ± 0.23	2.55 ± 0.79
INV-Ctrl	8.94 ± 0.23	2.50 ± 0.47	153.8 ± 2.95	944.8 ± 84.2	0.38 ± 0.13	1.92 ± 0.65
DT18	8.90 ± 0.14	2.60 ± 1.26	151.2 ± 2.17	997.8 ± 99.3	0.32 ± 0.33	2.22 ± 0.92
F value	0.032	0.175	1.192	0.931	0.31	0.695
P value	0.969	0.842	0.340	0.423	0.739	0.520

Data were analyzed by one-way ANOVA followed by the Dunnett test. The DT18 group was compared with the saline group and INV-Ctrl group (n = 5).

ISSN: 1528-3658